The effects of estrogen and testosterone on gene expression in the rat mesenteric arteries

Vascular Pharmacology

Volumn 47, Issue 4, 2007, Pages 238-247

  Eyster, Kathleen M ^a   Mark, Connie J ^a   Gayle, Richard ^b   Martin, Douglas S ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b BLACK HILLS STATE UNIVERSITY   (United States)

Author keywords

Differential expression; DNA microarray; Gender; Steroid; Vasculature

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; ALBUMIN; DNA; DNA BINDING PROTEIN; ESTRADIOL BENZOATE; FATTY ACID SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1BETA; INTERLEUKIN 4 RECEPTOR; PROTEIN C FOS; RNA; SESAME SEED OIL; TESTOSTERONE; TRANSCRIPTION FACTOR JUNB;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HORMONE ACTION; HORMONE RESPONSE; MESENTERIC ARTERY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROMOTER REGION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SPRAGUE DAWLEY RAT;

3-ALPHA-HYDROXYSTEROID DEHYDROGENASE (B-SPECIFIC); ANIMALS; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENES, FOS; GENES, JUN; IMMUNOENZYME TECHNIQUES; MESENTERIC ARTERIES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, INTERLEUKIN-4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERUS;

EID: 34548826785     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.06.007     Document Type: Article

References (73)

1. Alonso A., Fernandez R., Moreno M., Ordonez P., Gonzalez-Pardo H., Conejo N.M., Diaz F., and Gonsalez C. Positive effects of 17β-estradiol on insulin sensitivity in aged ovariectomized female rats. J. Geron. Biol. Sci. 61A (2006) 419-426
2. Aprahamian S., Arslanian M.J., and Stoops J.K. Effect of estrogen on fatty acid synthetase in the chicken oviduct and liver. Lipids 14 (1979) 1015-1020
3. Bedran-de-Castro M.T., and Bedren-de-Castro J.C. Effect of testosterone on the pressor response to common carotid occlusion in gonadectomized conscious male rats with lesion of the median eminence. Braz. J. Med. Biol. Res. 24 (1991) 961-965
4. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball C.A., Causton H.C., Gaasterland T., Glenisson P., Holstege F.C., Kim I.F., Markowitz V., Matese J.C., Parkinson H., Robinson A., Sarkans U., Schulze-Kremer S., Stewart J., Taylor R., Vilo J., and Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29 (2001) 365-371
5. Bulun S.E., and Adashi E.Y. The physiology and pathology of the female reproductive axis. In: Larsen P.R., Kronenberg H.M., Melmed S., and Polonsky K.S. (Eds). Williams Textbook of Endocrinology (2003), Saunders, Philadelphia, PA 587-664
6. Calhoun D.A., and Oparil S. Gender and blood pressure. Hypertension Primer. 2nd Edition (1999) 229-232
7. Chinenov Y., and Kerppola T.K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20 (2001) 2438-2452
8. Chinetti G., Fruchart J.-C., and Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall. Z. Kardiol. 90 Suppl 3 (2001) III/125-III/132
9. Christensen K.L., and Mulvany M.J. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J. Vasc. Res. 30 (1993) 73-79
10. Cicatiello L., Ambrosino C., Coletta B., Scalona M., Sica V., Bresciani F., and Weisz A. Transcriptional activation of jun and actin genes by estrogen during mitogenic stimulation of rat uterine cells. J. Steroid Biochem. Mol. Biol. 41 (1992) 523-528
11. Colucci W.S., Gimbrone Jr. M.A., McLaughlin M.K., Halpern W., and Alexander R.W. Increased vascular catecholamine sensitivity and alpha adrenergic receptor affinity in female and estrogen treated male rats. Circ. Res. 50 (1982) 805-811
12. Dalle Lucca J.J., Adeagbo A.S.O., and Alsip N.L. Influence of eostrous cycle and pregnancy on the reactivity of the rat mesenteric vascular bed. Hum. Reprod. 15 (2000) 961-968
13. Darkow D.J., Lu L., and White R.E. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP. Am. J. Physiol. 272 (1997) H2765-H2773
14. Ding A.Q., and Stallone J.N. Testosterone induced relaxation of rat aorta is androgen structure specific and involves K channel activation. J. Appl. Physiol. 91 (2001) 2742-2750
15. Dubey R.K., Oparil S., Imthurn B., and Jackson E.K. Sex hormones and hypertension. Cardiovasc. Res. 53 (2002) 688-708
16. Dufort I., Soucy P., Lacoste L., and Luu-The V. Comparative biosynthetic pathway of androstenol and androgens. J. Steroid Biochem. Mol. Biol. 77 (2001) 223-227
17. Farhat M.Y., Lavigne M.C., and Ramwell P.W. The vascular protective effects of estrogen. FASEB J. 10 (1996) 615-624
18. Fujimoto R., Morimoto I., Morita E., Sugimoto H., Ito Y., and Eto S. Androgen receptors, 5 alpha-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells. J. Steroid Biochem. Mol. Biol. 50 (1994) 169-174
19. Gonzales R.J., Krause D.N., and Duckles S.P. Testosterone suppresses endothelium-dependent dilation of rat middle cerebral arteries. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) H552-H560
20. Hashimura K., Sudhir K., Nigro J., Ling S., Williams M.R., Komesaroff P.A., and Little P.J. Androgens stimulate human vascular smooth muscle cell proteoglycan biosynthesis and increase lipoprotein binding. Endocrinology 146 (2005) 2085-2090
21. Heemers H., Vanderhoydonc F., Roskams T., Shechter I., Heyns W., Verhoeven G., and Swinnen J.V. Androgens stimulate coordinated lipogenic gene expression in normal target tissues in vivo. Mol. Cell. Endocrinol. 205 (2003) 21-31
22. Hellemans J., Mortier G., De Paepe A., Speleman F., and Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 8 (2007) R19
23. Hemmings D.G., Xu Y., and Davidge S.T. Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. Br. J. Pharmacol. 143 (2004) 276-284
24. Huang J.T., Welch J.S., Ricote M., Binder C.J., Willson T.M., Kelly C., Witztum J.L., Funk C.D., Conrad D., and Glass C.K. Interleukin-4-dependent production of PPARγ ligands in macrophages by 12/15-lipoxygenase. Nature 400 (1999) 378-382
25. Ing N.H., and Zhang Y. Cell-specific expression of estrogen-responsive genes in the uteri of cyclic, early pregnant and ovariectomized ewes. Theriogenology 62 (2004) 403-414
26. Jiang H., Harris M.B., and Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J. Allergy Clin. Immunol. 105 (2000) 1063-1070
27. Karas R.H., Patterson B.L., and Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89 (1994) 1943-1950
28. Kewley R.J., Whitelaw M.L., and Chapman-Smith A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell Biol. 36 (2004) 189-204
29. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., and Lehmann J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. 94 (1997) 4318-4323
30. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., and Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74 (2000) 311-317
31. Lee C.-H., Olson P., and Evans R.M. Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144 (2003) 2201-2207
32. Manning R., Courtney S., and Talbot S. Temporal changes in plasma and liver lipids and in the hepatic activities of acetyl-coenzyme a carboxylase and fatty acid synthetase after oestrogen treatment of the male chicken (Gallus domesticus). Int. J. Biochem. 21 (1989) 517-523
33. Mechta-Grigoriou F., Gerald D., and Yaniv M. The mammalian Jun proteins: redundancy and specificity. Oncogene 20 (2001) 2378-2389
34. Mendelsohn M.E. Mechanisms of estrogen action in the cardiovascular system. J. Steroid Biochem. Mol. Biol. 74 (2000) 337-343
35. Nagar D., Liu X.T., and Rosenfeld C.R. Estrogen regulates {beta}-1-subunit expression in Ca(2+)-activated K(+) channels in arteries from reproductive tissues. Am. J. Physiol, Heart Circ. Physiol. 289 (2005) H1417-H1427
36. Nelms K., Huang H., Ryan J., Keegan A., and Paul W.E. Interleukin-4 receptor signalling mechanisms and their biological significance. In: Gupta (Ed). Mechanisms of Lymphocyte Activation and Immune Regulation vol. VII (1998), Plenum Press, New York 37-43
37. Neves L.A., Averill D.B., Ferrario C.M., Aschner J.L., and Brosnihan K.B. Vascular responses to angiotensin-(1-7) during the estrous cycle. Endocrine 24 (2004) 161-165
38. Ojeda S.R., and Urbanski H.F. Puberty in the rat. In: Knobil E., and Neill J.D. (Eds). The Physiology of Reproduction (1988), Raven Press, New York 1699-1737
39. Okada A., Ohta Y., Brody S.L., and Iguchi T. Epithelial c-jun and c-fos are temporally and spatially regulated by estradiol during neonatal rat oviduct differentiation. J. Endocrinol. 182 (2004) 219-227
40. Oparil S. Hormones and vasoprotection. Hypertension 33 part II (1999) 170-176
41. Owens J.W., and Ashby J. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Crit. Rev. Toxicol. 32 (2002) 445-520
42. Paech K., Webb P., Kuiper G.G.J.M., Nilsson S., Gustafsson J.-A., Kushner P.J., and Scanlan T.S. Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites. Science 277 (1997) 1508-1510
43. Penning T.M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr. Rev. 18 (1997) 281-305
44. Piercy K.T., Donnell R.L., Kilpatrick S.S., Timaran C.H., Stevens S.L., Freeman M.B., and Goldman M.H. Effects of estrogen, progesterone, and combination exposure on interleukin-1 beta-induced expression of VCAM-1, ICAM-1, PECAM, and E-selectin by human female iliac artery endothelial cells. J. Surg. Res. 105 (2002) 215-219
45. Pocar P., Fischer B., Klonisch T., and Hombach-Klonisch S. Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction 129 (2005) 379-389
46. Poff C.D., and Balazy M. Drugs that target lipoxygenases and leukotrienes as emerging therapies for asthma and cancer. Curr. Drug Targets-Inflamm. Allergy 3 (2004) 19-33
47. Ramakrishnan R., Dorris D., Lublinsky A., Nguyen A., Domanus M., Prokhorova A., Gieser L., Touma E., Lockner R., Tata M., Zhu X., Patterson M., Shippy R., Sendera T.J., and Mazumder A. An assessment of Motorola CodeLink microarray performance for gene expression profiling applications. Nucleic Acids Res. 30 (2002) e30
48. Reckelhoff J.F. Sex steroids, cardiovascular disease, and hypertension. Unanswered questions and some speculations. Hypertension 45 (2005) 170-174
49. Reckelhoff J.F., Zhang J., and Granger J.P. Testosterone exacerbates hypertension and reduces pressure natriuresis in male spontaneously hypertensive rats. Hypertension 31 (1998) 435-439
50. Reckelhoff J.F., Zhang H., Srivastava K., and Granger J.P. Gender differences in hypertension in spontaneously hypertensive rats. Role of androgens and androgen receptor. Hypertension 34 (1999) 920-923
51. Rivera-Gonzalez R., Petersen D.N., Tkalcevic G., Thompson D.D., and Brown T. Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen. J. Steroid Biochem. Mol. Biol. 64 (1998) 13-24
52. Rodrigo M.C., Martin D.S., Redetzke R.A., and Eyster K.M. A method for the extraction of high quality RNA and protein from single small samples of arteries and veins preserved in RNAlater. J. Pharmacol. Toxicol. Methods 47 2 (2002) 87-92
53. Rodrigo M.C., Martin D.S., and Eyster K.M. Estrogen decreases biglycan mRNA expression in resistance blood vessels. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R754-R761
54. Rodrigo M.C., Martin D.S., and Eyster K.M. Vascular ECE-1 mRNA expression decreases in response to estrogen. Life Sci. 73 (2003) 2973-2983
55. Rosano G.M., Cornoldi A., and Fini M. Effects of androgens on the cardiovascular system. J. Endocrinol. Investig. 28 3 Suppl (2005) 32-38
56. 2 receptor components in rat mesenteric artery. Endocrinology 147 (2006) 389-396
57. Safe S., Wormke M., and Samudio I. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. J. Mammary Gland Biol. Neoplasia 5 (2000) 295-306
58. Sauma L., Stenkula K.G., Kjolhede P., Stralfors P., Soderstrom M., and Nystrom F.H. PPAR-γ response element activity in intact primary human adipocytes: effects of fatty acids. Nutrition 22 (2006) 60-68
59. Semenkovich C.F. Regulation of fatty acid synthase (FAS). Prog. Lipid Res. 36 (1997) 43-53
60. Shaw L., Taggart M., and Austin C. Effects of the oestrous cycle and gender on acute vasodilatory responses of isolated pressurized rat mesenteric arteries to 17β-oestradiol. Br. J. Pharmacol. 132 (2001) 1055-1062
61. Shankar S.S., and Steinberg H.O. FFAs: do they play a role in vascular disease in the insulin resistance syndrome?. Curr. Diab. Rep. 5 (2005) 30-35
62. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 (2002) E131-E136
63. Song J., and Martin D.S. Rho kinase contributes to androgen amplification of renal vasoconstrictor responses in the spontaneously hypertensive rat. J. Cardiovasc. Pharmacol. 48 (2006) 103-109
64. Song D., Arikawa E., Galipeau D.M., Yeh J.N., Battell M.L., Yuen V.G., and McNeill J.H. Chronic estrogen treatment modifies insulin-induced insulin resistence and hypertension in ovariectomized rats. Am. J. Hypertens. 18 (2005) 1189-1194
65. Song J., Kost C., and Martin D.S. Androgens augment renal vascular responses to angiotensin II in New Zealand genetically hypertensive rats. Am. J. Physiol. 290 (2006) R1608-R1615
66. Song J., Kost C., and Martin D.S. Androgens potentiate renal vascular responses to angiotensin II via amplification of the rho kinase signaling pathways. Cardiovasc. Res. 72 (2006) 456-463
67. Speroff L. WHI estrogen-only arm is canceled. Maturitas 48 (2004) 3-4
68. Stepniakowski K.T., Sallee F.R., Goodfriend T.L., Zhang Z., and Egan B.M. Fatty acids enhance neurovascular reflex responses by effects on alpha 1-adrenoceptors. Am. J. Physiol. 270 (1996) R1340-R1346
69. Toba K., Crofton J.T., Inoue M., and Share L. Effects of vasopressin on arterial blood pressure and cardiac output in male and female rats. Am. J. Physiol. 261 (1991) R1118-R1125
70. Wolting C.D., and McGlade C.J. Cloning and chromosomal localization of a new member of the bHLH/PAS transcription factor family. Mamm. Genome 9 (1998) 463-468
71. Writing group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
72. Wuarin J., and Schibler U. Expression of the liver-enriched transcriptional activator protein DBP follows a stringent circadian rhythm. Cell 63 (1990) 1257-1266
73. Yallampalli C., Kondapaka S.B., Lanlua P., Wimalawansa S.J., and Gangula P.R.R. Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta. Biol. Reprod. 70 (2004) 1055-1062